NASDAQ$OCGN

Ocugen Inc · Q2 2017 earnings

Q2 2017 earnings · · Investor relations

Headline financials

EPS (adj)

-$15.00

Previous: -$36.60+59.0%
Net Income

-$6.54M

Previous: -$8.04M+18.6%
Operating Income

-$6.37M

Previous: -$7.96M+19.9%
Gross Profit

$0.00

Previous: $0.00
R&D Expense

$4.21M

Previous: $5.79M-27.4%

Revenue & EPS history

Ocugen · Revenue · Quarterly

$1.53M

Q1 2026+3.5%vs Q1 2025

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2017

Historical avgQ2 2017

-1.2%

Avg return

Earnings day

-2.7%

Avg return

5 days after

-3.7%

Avg return

30 days after

42%

19 / 45 earnings

Positive

+31.5%

Q1 2016

Best reaction

-27.5%

Q3 2019

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.0%+1.0%-12.0%
Q4 2025+5.4%-10.8%-3.8%
Q3 2025-1.4%-5.6%-14.7%
Q1 2025-2.3%+0.9%+53.8%
Q4 2024-2.8%-5.8%+12.2%
Q3 2024-0.9%-11.3%-19.4%
Q2 2024+5.9%+11.9%-3.4%
Q1 2024+8.3%+5.5%-16.0%
Q4 2023-9.4%-17.0%+24.5%
Q3 2023-6.3%-2.6%+1.3%
Q2 2023-8.8%+3.4%-10.4%
Q1 2023+3.3%+7.3%-32.1%
Q4 2022+2.3%+6.6%-15.6%
Q3 2022-3.3%+15.7%-8.5%
Q2 2022+2.9%+2.2%-13.4%
Q1 2022-12.3%-19.7%+0.4%
Q4 2021+15.0%+14.9%+13.9%
Q3 2021-11.4%-8.4%-41.3%
Q2 2021+8.4%+5.2%-0.8%
Q1 2021+6.2%-10.1%-9.0%
Q4 2020-6.6%-15.4%-39.5%
Q3 2020+1.4%+3.8%+8.0%
Q2 2020-20.2%-23.0%-48.8%
Q1 2020+0.0%-5.2%-24.2%
Q4 2019-15.7%-19.1%-11.1%
Q3 2019-27.5%-50.6%-64.7%
Q2 2019+4.3%-1.1%+43.9%
Q1 2019-4.7%-8.8%+54.9%
Q4 2018-7.1%-7.9%+52.8%
Q3 2018-4.7%-17.8%-9.3%
Q2 2018+6.1%+17.4%-68.9%
Q1 2018-2.3%-17.3%+7.3%
Q4 2017-3.3%-1.3%-5.3%
Q3 2017-5.2%-9.8%-9.9%
Q2 2017+2.2%-0.6%+6.7%
Q1 2017-1.2%-1.2%+0.0%
Q4 2016+1.1%-9.0%+0.0%
Q3 2016-3.7%-9.4%-23.8%
Q2 2016+7.1%+86.4%+82.8%
Q1 2016+31.5%
Q4 2015+8.9%
Q3 2015-16.6%
Q2 2015+3.0%
Q1 2015-2.5%
Q4 2014+4.2%
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro